Starting on:
Oct 31, 2024
Ending on:
Oct 31, 2024
Moderator(s):
KPA Monthly CME Webinar
Max Credits:
3 Points
Provider:
Kenya Psychiatrists Association
Claim Points
Oct 31, 2024
Ending on:
Oct 31, 2024
Moderator(s):
Dr.
Stacy Njani
Psychiatry Resident, University of Nairobi
Venue: Psychiatry Resident, University of Nairobi
KPA Monthly CME Webinar
Max Credits:
3 Points
Provider:
Kenya Psychiatrists Association
Claim Points
Role of Fluoxetine + Olanzapine combination therapy to manage Treatment-Resistant Depression
Starting on:
Oct 31, 2024
Oct 31, 2024
Ending on:
Oct 31, 2024
Oct 31, 2024
Venue:
KPA Monthly CME Webinar
KPA Monthly CME Webinar
Description
Kenya Psychiatric Association, in collaboration with NabiQasim Industries Pvt Ltd, hosted an insightful webinar on the use of Fluoxetine and Olanzapine combination therapy in managing treatment-resistant depression. This session brought together leading experts in psychiatry to discuss the efficacy, clinical considerations, and outcomes associated with this combination treatment approach.
Objectives
Overview of treatment-resistant depression and challenges in management
Mechanism of action and benefits of the Fluoxetine + Olanzapine combination
Patient case studies and evidence-based outcomes
Practical guidelines for clinicians
This session was accredited with 3 CPD Points and is ideal for psychiatrists, psychologists, and mental health professionals interested in advancing their knowledge of combination therapies in psychiatry.
Presenters
-
Dr.
Catherine Syengo
Consultant Psychiatrist
Mathari National Teaching and Referral Hospital -
Dr.
Raza Rahman
Meritorious Professor & Chairman
Psychiatry at Dow University of Health Sciences